ClinicalTrialsFinder

Acute Lymphoid Leukemia Relapse Clinical Trials in Hamburg, Free and Hanseatic City of Hamburg

1 recruitingHamburg, Free and Hanseatic City of Hamburg, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia

ALL, Childhood B-CellAcute Lymphoid Leukemia RelapseAcute Lymphocytic Leukemia Refractory
University Hospital Tuebingen20 enrolled11 locationsNCT05366218